Fear and drugs of ingredients of buprenorphine (a real world drug study)


Summary:

Fear is found among people who take drugs with ingredients of buprenorphine, especially for people who are female, 50-59 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 77,111 people who have side effects when taking drugs with ingredients of buprenorphine from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Brixadi, Buprenorphine, Butrans, Sublocade.


On Aug, 07, 2026

77,111 people reported to have side effects when taking drugs with ingredients of buprenorphine.
Among them, 43 people (0.06%) have Fear


What is Fear?

Fear is found to be associated with 1,419 drugs and 1,583 conditions by eHealthMe. Check the latest studies of Fear.

Number of reports submitted per year:

Could drugs with ingredients of buprenorphine cause Fear?

Time on drugs with ingredients of buprenorphine when people have Fear *:

  • < 1 month: 62.5 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 25.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 12.5 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Fear when taking drugs with ingredients of buprenorphine *:

  • female: 65.12 %
  • male: 34.88 %

Age of people who have Fear when taking drugs with ingredients of buprenorphine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 10.53 %
  • 30-39: 10.53 %
  • 40-49: 21.05 %
  • 50-59: 42.11 %
  • 60+: 15.79 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Back Pain: 6 people, 13.95%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 4.65%
  3. Overdose: 2 people, 4.65%
  4. Neuralgia (pain in one or more nerves): 2 people, 4.65%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 4.65%
  6. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 2.33%
  7. Bladder Disorder: 1 person, 2.33%
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 2.33%
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 2.33%
  10. Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 1 person, 2.33%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Oxycontin: 15 people, 34.88%
  2. Dilaudid: 11 people, 25.58%
  3. Hydrocodone Bitartrate And Acetaminophen: 9 people, 20.93%
  4. Ms Contin: 8 people, 18.60%
  5. Ryzolt: 7 people, 16.28%
  6. Oxycodone: 4 people, 9.30%
  7. Hysingla Er: 4 people, 9.30%
  8. Oxycodone Hydrochloride: 2 people, 4.65%
  9. Suboxone: 2 people, 4.65%
  10. Opana: 2 people, 4.65%

Other side effects people have besides Fear *:

You may use this to check any potential undetected side effects.

  1. Drug Dependence: 17 people, 39.53%
  2. Overdose: 16 people, 37.21%
  3. Stress And Anxiety: 15 people, 34.88%
  4. Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 14 people, 32.56%
  5. Nausea (feeling of having an urge to vomit): 13 people, 30.23%
  6. Dizziness: 12 people, 27.91%
  7. Constipation: 9 people, 20.93%
  8. Depression: 8 people, 18.60%
  9. Feeling Abnormal: 8 people, 18.60%
  10. Hyperhidrosis (abnormally increased sweating): 8 people, 18.60%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of buprenorphine, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: